Arkolith/Insider Trading/OMGA/Form 4

Flagship Pioneering Fund VI, L.P.

10% OwnerOmega Therapeutics, Inc. (OMGA) · full profile →Form 4 · filed Aug 5, 2021
Net Buying
Open-Market Buys
$20.0M
Open-Market Sells
$0
Net Open-Market Flow
$20.0M
Transactions
20
9 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 3, 2021Conversion(C)1.1M——1.1M
Aug 3, 2021Conversion(C)5.9M——5.9M
Aug 3, 2021Conversion(C)8.4M——8.4M
Aug 3, 2021Buy(P)221K$17.00$3.7M8.6M
Aug 3, 2021Buy(P)294K$17.00$5.0M1.6M
Aug 3, 2021Conversion(C)4.9M——4.9M
Aug 3, 2021Buy(P)662K$17.00$11.2M5.5M
Aug 3, 2021Conversion(C)1.3M——1.3M
Aug 3, 2021Conversion(C)971K——971K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 3, 2021Conversion(C)27.4M——0
Aug 3, 2021Conversion(C)3.3M——0
Aug 3, 2021Conversion(C)1.7M——0
Aug 3, 2021Conversion(C)5.0M——0
Aug 3, 2021Conversion(C)4.1M——0
Aug 3, 2021Conversion(C)22.3M——0
Aug 3, 2021Conversion(C)1.7M——0
Aug 3, 2021Conversion(C)3.0M——0
Aug 3, 2021Conversion(C)2.7M——0
Aug 3, 2021Conversion(C)667K——0
Aug 3, 2021Conversion(C)13.3M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-031796) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML